C-1. BIOACTIVE PURITY & CONCENTRATION ENHANCEMENT
C-2. BIOACTIVE STABILITY & PRESERVATION
C-3. NANO-SCALE PROCESSING
1-1. BIOACTIVE PURITY & CONCENTRATION ENHANCEMENT
The core plant-derived bioactives we use are not conventional plant extracts. They are low-molecular-weight plant peptides obtained through plant protein extraction and controlled enzymatic hydrolysis/peptidization.
Plant Extracts and Plant Peptides are not the same type of active material.
Conventional plant extracts are generally produced by using water, alcohol, or other solvents to extract soluble components from plant materials. The resulting extract is a complex mixture that may simultaneously contain polyphenols, sugars, organic acids, pigments, minerals, and many other plant-derived constituents.
Therefore, adding 1% of a plant extract does not mean that the product contains 1% of a specific effective bioactive substance.
PLANT PEPTIDES FOLLOW A DIFFERENT PATHWAY
Plant peptides originate from plant proteins rather than from the conventional extraction of soluble plant constituents.
Plant → Plant Protein Extraction → Enzymatic Hydrolysis / Peptidization → Low-Molecular-Weight Plant Peptides
Proteins are large molecules composed of many amino acids. Through controlled enzymatic hydrolysis and peptidization, these large protein molecules are cleaved into shorter peptide chains.
During our peptidization process, molecular weight is controlled to below 500 Da. Substances with a molecular weight below approximately 500 Da are generally considered more favorable for transdermal penetration and are more likely to pass through the skin barrier, particularly the stratum corneum.
Therefore, what we obtain is not simply an “extract” containing a mixture of different plant constituents. Our objective is to obtain active materials enriched in low-molecular-weight plant peptides.
C-1
1-2.FURTHER DE-SUGARING AND PURIFICATION
Commercial production of plant extracts and plant peptides is often located near the agricultural regions where the plant raw materials are grown.
After plant proteins have been extracted and enzymatically hydrolyzed into peptides, maltodextrin is commonly added as a carrier to facilitate drying, long-term storage, and transportation. The material is then processed into a commercially usable plant peptide powder.
As a result, commercially available plant peptide powder is not necessarily composed entirely of plant peptides. It may contain a substantial proportion of maltodextrin or other carrier material.
After obtaining the plant peptide powder, we do not simply add it directly into the final product.
We perform an additional specialized de-sugaring and purification process to remove more than 30% of the maltodextrin carrier, thereby increasing the proportion of actual low-molecular-weight plant peptides.
Therefore:
Adding 1% plant peptide powder does not necessarily mean that the final product contains 1% effective plant peptides.
This is why simply comparing the labeled “addition percentage” of an ingredient does not accurately represent the actual concentration, purity, or quality of the active material present in the final formulation.
C-2. BIOACTIVE STABILITY & PRESERVATION
ADDING AN ACTIVE INGREDIENT DOES NOT MEAN THAT IT WILL REMAIN IN ITS ORIGINAL ACTIVE STATE
Many natural bioactive substances, particularly natural plant polyphenols, have significant research value but also present substantial stability challenges.
Oxygen, light, temperature, pH, and the surrounding formulation environment can all affect these sensitive bioactives. They may undergo oxidation, covalent bonding reactions such as quinone–amine reactions, non-covalent complexation, structural alteration, or gradual loss of their original biological activity.
Therefore, the question we study is not simply:
“How much is added?”
The more important question is:
“After it has been incorporated into the formulation, how much of the active material can actually be preserved?”
According to the different physical and chemical characteristics of individual bioactives, we use different carrier systems and nano-scale encapsulation approaches to reduce the direct exposure of sensitive active substances to unsuitable environmental conditions.
Our encapsulation technology primarily considers four objectives:
Protect the Bioactive → Improve Stability → Improve Compatibility → Control Appropriate Release
Encapsulation, therefore, is not simply an isolated “microcapsule” concept. It is an important part of the entire bioactive-processing strategy and of the design required to preserve functional performance in the final product.
C-3. NANO-SCALE PROCESSING
A HIGHER ADDITION LEVEL DOES NOT NECESSARILY MEAN HIGHER EFFECTIVE UTILIZATION
Some natural bioactive substances are limited by molecular aggregation, particle size, solubility, and dispersibility.
For this reason, we conduct further micronization and nano-scale processing research according to the specific characteristics of different bioactive materials.
The objective is not simply to pursue the label “Nano.”
The purpose is to improve how the active material behaves in its final application
environment in terms of:
Particle Size | Dispersion | Stability | Compatibility | Effective Utilization
When high-purity bioactives are further subjected to appropriate nano-scale processing and encapsulation, the meaningful comparison is no longer simply:
0.1% vs. 1%
The more important question becomes:
How much of the truly effective bioactive material ultimately remains available for utilization?
This is an important foundation of our ability to achieve higher effective utilization and stronger functional performance at comparatively lower actual addition levels.